Literature DB >> 26239118

DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling.

Soo-Yeon Park1, Hyo-Kyoung Choi2, Jae Sung Seo1, Jung-Yoon Yoo3, Jae-Wook Jeong4, Youngsok Choi5, Kyung-Chul Choi6, Ho-Geun Yoon7.   

Abstract

Mitogen-inducible gene 6 (MIG6) is a tumor suppressor implicated in the development of human cancers; however, the regulatory mechanisms of MIG6 remain unknown. Here, using a yeast two-hybrid screen, we identified DnaJ homolog subfamily B member I (DNAJB1) as a novel MIG6-interacting protein. We found that DNAJB1 binds to and decreases MIG6 protein, but not mRNA, levels. DNAJB1 overexpression dosage-dependently decreased MIG6 protein levels. Conversely, DNAJB1 knockdown increased MIG6 protein levels. DNAJB1 destabilizes MIG6 by enhancing K48-linked ubiquitination of MIG6. However, knocking-down of DNAJB1 reduced the ubiquitination of MIG6. DNAJB1 positively regulates the epidermal growth factor receptors (EGFR) signaling pathway via destabilization of MIG6; however, DNAJB1 knockdown diminishes activation of EGFR signaling as well as elevation of MIG6. Importantly, the increased levels of MIG6 by DNAJB1 knockdown greatly enhanced the gefitinib sensitivity in A549 cells. Thus, our study provides a new molecular mechanism to regulate EGFR signaling through modulation of MIG6 by DNAJB1 as a negative regulator.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  DNAJB1; EGFR; Gefitinib; Lung cancer; MIG6

Mesh:

Substances:

Year:  2015        PMID: 26239118     DOI: 10.1016/j.bbamcr.2015.07.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

Review 2.  Feedback regulation of RTK signaling in development.

Authors:  Cynthia L Neben; Megan Lo; Natalia Jura; Ophir D Klein
Journal:  Dev Biol       Date:  2017-10-26       Impact factor: 3.582

3.  Hsp40s play distinct roles during the initial stages of apolipoprotein B biogenesis.

Authors:  Deepa Kumari; Edward A Fisher; Jeffrey L Brodsky
Journal:  Mol Biol Cell       Date:  2021-12-15       Impact factor: 3.612

Review 4.  The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.

Authors:  Cécile Naudin; Clément Chevalier; Serge Roche
Journal:  Oncotarget       Date:  2016-03-08

5.  Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma.

Authors:  Chongze Yuan; Hong Hu; Muyu Kuang; Zongwei Chen; Xiaoting Tao; Shengjian Fang; Yihua Sun; Yawei Zhang; Haiquan Chen
Journal:  Oncotarget       Date:  2017-10-27

Review 6.  Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.

Authors:  Erhong Meng; Lalita A Shevde; Rajeev S Samant
Journal:  Oncotarget       Date:  2016-08-16

7.  Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.

Authors:  Shikha Roy; Rakesh Kumar; Vaibhav Mittal; Dinesh Gupta
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

Review 8.  Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.

Authors:  Chul Won Yun; Hyung Joo Kim; Ji Ho Lim; Sang Hun Lee
Journal:  Cells       Date:  2019-12-24       Impact factor: 6.600

9.  A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism.

Authors:  Sanjay Pal; Nihal Medatwal; Sandeep Kumar; Animesh Kar; Varsha Komalla; Prabhu Srinivas Yavvari; Deepakkumar Mishra; Zaigham Abbas Rizvi; Shiv Nandan; Dipankar Malakar; Manoj Pillai; Amit Awasthi; Prasenjit Das; Ravi Datta Sharma; Aasheesh Srivastava; Sagar Sengupta; Ujjaini Dasgupta; Avinash Bajaj
Journal:  ACS Cent Sci       Date:  2019-10-10       Impact factor: 14.553

10.  Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.

Authors:  Hongyue Ren; Mingxu Luo; Jinzhong Chen; Yanming Zhou; Xiumei Li; Yanyan Zhan; Dongyan Shen; Bo Chen
Journal:  Oncol Rep       Date:  2019-10-23       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.